<DOC>
	<DOC>NCT00876148</DOC>
	<brief_summary>The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.</brief_summary>
	<brief_title>Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>All patients undergoing an allograft for hematological malignancies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Incidence of hepatitis B after allografting</keyword>
	<keyword>Risk of hepatitis B reactivation</keyword>
	<keyword>Lamivudine prophylaxis</keyword>
</DOC>